Effect of fumonisin B1 on rat hepatic P450 system

Environmental Toxicology and Pharmacology

Volumn 8, Issue 3, 2000, Pages 197-204

  Spotti, Maura ^a   Maas, Roel F M ^a   De Nijs, Cornelia M ^b   Fink Gremmels, Johanna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Cytochrome P450; Fumonisin B1; Liver; Rat

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 3A; DIMETHYLNITROSAMINE DEMETHYLASE; FUMONISIN B1; ISOENZYME; PENTOXYRESORUFIN DEALKYLASE; PHENACETIN O DEETHYLASE; PROTEIN KINASE; SPHINGOLIPID;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH RETARDATION; MALE; METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0033912947     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(00)00040-5     Document Type: Article

References (56)

1. 1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology. 131:1998;121.
2. Amet Y., Berthou F., Goasduf T., Salaun J.P., Le Breton L., Menez J.F. Evidence that cytochrome P4502E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Commun. 203:1994;1168.
3. Amet Y., Berthou F., Baird S., Dreano Y., Bail J.P., Menez J.F. Validation of the (ω-1) hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochem. Pharmacol. 50:1995;1775.
4. Arlotto M.P., Trant J.M., Estabrook R.W. Measurement of steroid hydroxylation reactions by high performance liquid chromatography as indicator of P-450 identity and function. Methods Enzymol. 206:1991;454.
5. 1-induced DNA damage in rat liver and spleen: effects of pretreatment with coenzyme Q10, L-carnitine, α-tocopherol and selenium. Pharmacol. Res. 40:1999;459.
6. Baldwin B.S.J., Bloomer J.C., Smith G.J., Ayrton A.D., Clarke S.E., Chenery R.J. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica. 25:1995;261.
7. Balsinde J., Balboa M.A., Dennis E.A. Inflammatory activation of arachidonic acid signalling in murine P388D1 macrophages via sphingomyelin synthesis. J. Biol. Chem. 272:1997;20373.
8. Berthou F., Guillois B., Ricje C., Deano Y., Jacqz-Aigrain E., Beaume P.H. Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22:1992;671.
9. Boucher J.L., Delaforge M., Salaun J.P., Pinot F., Durst F., Pflieger P., Mioskowski C. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogues by rat liver microsomes. Drug Metab. Dispos. 24:1996;462.
10. Bullerman L.B., Tsai W.Y.J. Incidence and levels of Fusarium moniliforme, Fusarium proliferatum and fumonisins in corn and corn-based foods and feeds. J. Food Prot. 57:1994;541.
11. Clarke S.E., Baldwin S.J., Bloomer J.C., Ayrton A.D., Sozio R.S., Chenery R.J. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem. Res. Toxicol. 7:1994;836.
12. Dong Z., Hong J., Ma Q., Li D., Bullock J., Gonzales F.J., Park S.S., Gelboin H.V., Yang C.S. Mechanism on induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch. Biochem. Biophys. 263:1988;29.
13. Fink-Gremmels J., Van Miert A.S.J.P.A.M. Species differences in biotransformation; conventional models in non-conventional animal species. Exp. Pathol. 48:1996;S120-S127.
14. Fink-Gremmels J., De Groene A.M. In vitro models in biotransformation processes. J. Vet. Pharmacol. Therap. 20:1997;17.
15. Funae Y., Imakoa S. Purification and characterisation of liver microsomal cytochrome P-450 from untreated rats. Biochim. Biophys. Acta. 926:1987;349.
16. Gelderblom W.C.A., Jaskiewics K., Marasas W.F.O., Thiel P.G., Horak R.M., Vleggaar R., Kriek N.P.J. The fumonisin B mycotoxins: novel cancer promoters produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54:1988;1806.
17. 1, in rats. Carcinogenesis. 12:1991;1247.
18. Gelderblom W.C.A., Semple E., Marasas W.F.O., Farber E. The cancer initiating potential of the fumonisin mycotoxins produced by Fusarium moniliforme. Carcinogenesis. 13:1992;433.
19. Gelderblom W.C.A., Cawood M.E., Snyman S.D., Vleggaar R., Marasas W.F.O. Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays. Food Chem. Toxicol. 31:1993;407.
20. 1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis. 15:1994;209.
21. 1 on rat hepatocytes in primary culture. Carcinogenesis. 16:1995;625.
22. 1 in primary rat hepatocytes. Prostaglandins Leukotrienes Essent. Fatty Acids. 61:1999;225.
23. Huang C., Dickman M., Henderson G., Jones C. Repression of protein kinase C of cyclic AMP response elements by fumonisin, a fungal encoded toxin, which is a carcinogen. Cancer Res. 55:1995;1655.
24. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. 56:1993;445-466 IARC, Lyon, France.
25. Kennedy S.W., Lorenzen A., James C.A., Collins B.T. Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal. Biochem. 22:1993;102.
26. Knasmuller S., Bresgen N., Kassie F., Mersch-Sundermann V., Gelderblom W., Zohrer E., Eckel P.M. Genotoxic effects of three Fusarium mycotoxins, fumonisin B, moniliformin and vomitoxin in bacteria and primary cultures of rat hepatocytes. Mutat. Res. 391:1997;39.
27. 1-induced cancer promotion in the rat liver. Cancer Lett. 146:1999;207.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
29. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharm. Toxicol. 37:1997;517.
30. 1. Toxicol. Appl. Pharm. 141:1996;185.
31. 1. Vet. Hum. Toxicol. 41:1999;357.
32. Merrill A.H. Jr, Liotta D.C., Riley R.T. Lipid second messengers. Bell R.H., Exton J.H., Prescott S.M. Handbook of Lipid Research. 8:1996;205-237 Plenum Press, New York.
33. Merrill A.H., Schmelz E.M., Dillehay D.L., Spiegel S., Shayman J.A., Schroder J.J., Riley R.T., Voss K.A., Wang E. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142:1997;208.
34. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: update of new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1.
35. Nedelcheva V., Gut I. P-450 in rat and man: methods of investigation substrate specificity and relevance to cancer. Xenobiotica. 24:1994;1151.
36. Nikolova-Karakashian M., Morgan E.T., Alexander C., Liotta D.C., Merrill A.H. Bimodal regulation of ceramidase by interleukin-1β. Implications for the regulation of cytochrome p450 2C11. J. Biol. Chem. 272:1997;18718.
37. Norred W.P., Voss K.A. Toxicity and role of fumonisins in animal diseases and human esophageal cancer. J. Food Prot. 57:1994;522.
38. 1 in F344/N rats and B6C3F1 mice. NTP TR 496 NIH, Publication No. 99-3995.
39. Reiners J.J., Cantu A.R., Scholler A. Phorbolester-mediated suppression of cytochrome P450 CYP1A1 induction in murine skin: involvement of protein kinase C. Biochem. Biophys. Res. Commun. 186:1992;970.
40. Rheeder J.P., Marasas W.F.O., Thiel P.G., Sydenham E.W., Shephard G.S., van Schalkwyk D.J. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathology. 82:1992;353.
41. Riley R.T., Voss K.A., Yoo H.S., Gelderblom W.C.A., Merrill A.H. Mechanism of fumonisin toxicity and carcinogenesis. J. Food Prot. 57:1994;528.
42. Riley R.T., Wang E., Schroeder J.J., Smith E.R., Plattner R.D., Abbas H., Yoo H.S., Merrill A.H. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins. 4:1996;3.
43. Ross P.F., Nelson P.E., Richard J.L., Osweiler G.D., Rice L.G., Plattner R.D., Wilson T.M. Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated with equine leukoencephalomalacia and a pulmonary edema syndrome in swine. Appl. Environ. Microbiol. 56:1990;3224.
44. Rutten A.J.J.L., Falke H.E., Castelburg J.F. Interlabolatory comparison of total P-450 and protein determinations in rat liver microsomes. Arch. Toxicol. 61:1987;27.
45. 1, in rats. Toxicon. 30:1992a;768.
46. 1 in rats. Food Chem. Toxicol. 30:1992b;277.
47. Shimada T., Mimura M., Inoue K., Nakamura S., Oda H., Ohmori S., Yamazaki H. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, monkeys, and humans. Arch. Toxicol. 71:1997;401.
48. Smith E.R., Jones P.L., Boss J.M., Merrill A.H. Jr Changing J774A.1 cells to new medium perturbs multiple signalling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J. Biol. Chem. 272:1997;5640.
49. Tollet P., Legraverend C., Gustafsson J.A., Mode A. A role for protein kinases in the growth hormone regulation of cytochrome P4502C12 and insulin-like growth factor-I messenger RNA expression in primary adult rat hepatocytes. Mol. Endocrinol. 5:1991;1351.
50. Voss K.A., Norred W.P., Plattner R.D., Bacon C.W. Hepatotoxicity and renal toxicity in rats of corn samples associated with field cases of equine leukoencephalomalacia. Food Chem. Toxicol. 27:1989;89.
51. 1. Nat. Toxins. 1:1993;222.
52. 1 in B6C3F1 mice and Fisher 344 rats. Fundam. Appl. Toxicol. 24:1994;102.
53. Wang E., Norred W.P., Bacon C.W., Riley R.T., Merrill A.H. Inhibition of sphingolipids biosynthesis by fumonisins: Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 226:1991;14486.
54. Waxman D.J., Dannan G.A., Guengerich F.P. Regulation of rats hepatic cytochrome P-450: age-dependent expression, hormonal imprinting and xenobiotic inducibility of sex-specific isozymes. Biochemistry. 24:1985;4409.
55. Wortelboer H.M., De Kruif C.A., Van Iersel A.A.J., Falke H.E., Noorhoek J., Blaauwboer B.J. The isoenzyme pattern of cytochrome P-450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and intact monolayers. Biochem. Pharmacol. 40:1990;2525.
56. Zangar R.C., Buhler D.R., Springer D.L. Neonatal exposure to xenobiotics alters adult hepatic protein kinase C α levels and testosterone metabolism: differential effects by diethylstilboestrol and phenobarbital. J. Toxicol. Environ. Health. 45:1995;47.